The vial supplied here is a research-grade co-lyophilized peptide blend, not a compounded medication
Who BPC-157 Is For You may be a fit for BPC-157 therapy if: The patients we see most often are professionals in their 40s and 50s who lift, run, cycle, or play recreational sports, and who can no longer push through injuries the way they did in their 20s and 30s
for example, MEF2A/D, a transcription factor that plays a significant role in synapse development, regulates the genes UBE3A , DIA1 , and PCDH10
The transition bumps
We already know that both the FDA and researchers have warned against glutathione IV therapy (IV drip)
Below is more information about how the drugs compare